Workflow
Silver47 Announces $14 Million Brokered LIFE Financing
aTyr PharmaaTyr Pharma(US:LIFE) Newsfileยท2025-08-25 21:31

Core Viewpoint - Silver47 Exploration Corp. has announced a brokered private placement to raise up to $14 million through the sale of units priced at $0.70 each, with the offering expected to close around September 16, 2025 [1][6]. Group 1: Offering Details - The offering consists of up to 20,000,000 units, each unit comprising one common share and one-half of a common share purchase warrant, with each whole warrant exercisable at $1.00 for 36 months [1][2]. - The company has granted agents an option to increase the offering size by up to $2.1 million [3]. - The offering is available to purchasers in all Canadian provinces except Quebec, relying on the "listed issuer financing exemption" [4]. Group 2: Use of Proceeds - The net proceeds from the offering will be used for further exploration work on the company's projects and for general working capital purposes [2]. Group 3: Financial Terms - The company will pay agents a cash commission of 6% of the gross proceeds and issue broker warrants equal to 6% of the units sold, exercisable at $0.70 for 36 months [7]. Group 4: Company Overview - Silver47 Exploration Corp. focuses on developing silver-rich deposits in North America, with a combined resource totaling 236 million ounces of silver equivalent at an inferred grade of 334 g/t and 10 million ounces at an indicated grade of 333 g/t [9]. - The company operates in Alaska, Nevada, and New Mexico, which are known for their prolific mining jurisdictions [9].